Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...

13d ago, source:

Vera Therapeutics Inc (NASDAQ:VERA), a clinical-stage biotechnology company focused on developing and commercializing ...

Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

1mon ago, source: WCBD

March 20, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for ...

Vera Therapeutics Stock (NASDAQ:VERA), Analyst Ratings, Price Targets, Predictions

2mon ago, source: Benzinga.com

Vera Therapeutics Inc has a consensus price target of $22.25, established from looking at the 30 latest analyst ratings. The last 3 analyst ratings were released from Guggenheim, Guggenheim ...

Buy Rating Affirmed on Vera Therapeutics Ahead of Key Atacicept Clinical Milestones

1mon ago, source: Business Insider

J.P. Morgan analyst Anupam Rama has reiterated their bullish stance on VERA stock, giving a Buy rating today. Anupam Rama has given his Buy rating due to a combination of factors surrounding the ...

Vera Therapeutics CFO sells over $4.6m in company stock

20d ago, source: Investing

Vera Therapeutics, Inc. (NASDAQ:VERA) Chief Financial Officer Sean Grant has recently engaged in significant trading of the company's stock, according to a new SEC filing. The transactions included ...

PTGX Protagonist Therapeutics, Inc.

2d ago, source: Seeking Alpha

Protagonist Therapeutics, Inc., a biopharmaceutical company ... phase 2 clinical trials for the treatment of polycythemia vera and other blood disorders; and JNJ-2113, an orally delivered ...

Vera Therapeutics Inc Class A VERA

8d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Vera Therapeutics Inc Class A

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Vera Therapeutics Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...